Michael Green, PhD

1K posts

Michael Green, PhD banner
Michael Green, PhD

Michael Green, PhD

@GreenLymphoLab

NZ born and raised researcher at @MDAndersonNews focused on the molecular basis for B-cell #lymphoma. Opinions are my own.

Houston, TX เข้าร่วม Mart 2015
606 กำลังติดตาม1.2K ผู้ติดตาม
Michael Green, PhD รีทวีตแล้ว
AACR
AACR@AACR·
Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more: brnw.ch/21x0OLd #AACRlymphoma26 @GreenLymphoLab
AACR tweet media
English
0
5
7
1.1K
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
Need PDX models for Lymphoma research? Check out our newest preprint: biorxiv.org/content/10.648… We generated and molecularly characterized 48 new models, including 23 from post-CAR T relapse biopsies. All are available to academic researchers through MTA. #lmsm
English
0
4
15
1.3K
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
I would prefer as an author that reviewers have the time they need to review the paper carefully. 4 days does not mean a lot in the life of a study that has taken multiple years.
English
0
0
1
157
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
10 day reviews: Is there any data to show that a 10 day reviewer deadline translates to a 4 day quicker turn-around time for authors? When the 4 day reduction in deadline removes a weekend from the review period it makes it much to spend the necessary time on the paper.
English
1
0
4
186
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
This provides an initial framework for understanding spatially resolved cellular ecosystems in DLBCL, highlighting how microenvironment architecture can shape disease biology. But we are just scratching the surface.
English
1
0
6
131
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
Interestingly, lymphomas of immune privileged sites (CNS & testis) have abundant T cells in close contact with tumor B cells that show evidence of activation and cytotixicity, but also hallmarks of exhaustion.
Michael Green, PhD tweet media
English
1
0
5
189
Michael Green, PhD รีทวีตแล้ว
Pavan Bachireddy
Pavan Bachireddy@pbachi·
Thrilled to share our 1st preprint (!) on @biorxiv “Molecular and cellular dynamics of measurable residual disease (#MRD) progression in myelodysplastic syndromes (MDS).” Led by the indefatigable Yu-Hsiang Chen in the lab (x.com/PhRMAfoundatio…). 👉👉biorxiv.org/content/10.110…
PhRMA Foundation@PhRMAfoundation

#PhF25 awardee Yu-Hsiang Chen, a postdoc @MDAndersonNews, is using single-cell technology to study #cancer cells that remain after stem cell transplant. Understanding these cells could help develop better treatments. @pbachi Watch the full interview: phrmafoundation.org/news-events/bl…

English
2
15
28
8.7K
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
@ESHaematology Thank you for the invitation to this wonderful conference in such a spectacular location.
English
0
0
2
89
ESH (Haematology)
ESH (Haematology)@ESHaematology·
Ignition on, this session is all about CAR T. Michael Green (@GreenLymphoLab) dissected mechanisms of CAR T resistance, including factors that impact refractoriness, early & late progression. #ESHCONFERENCES #ESHLYMPHOID2025 Chairs: Veronika Bachanova, Martin Hutchings
ESH (Haematology) tweet mediaESH (Haematology) tweet media
English
1
4
17
1.8K
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
@DelgoffeLab Never seen this before, but can't say I'm surprised. Glad you caught it - for now. On the bright side: mimicry is the sincerest form of flattery.
English
1
0
2
743
Delgoffe Lab
Delgoffe Lab@DelgoffeLab·
I want to share a harrowing scientific experience, without exposing too many details, to see if any of my Twitter science friends have seen the same. I was asked to review a ms from a low-mid impact journal. The title caught my eye, so I agreed, but was in for a surprise. 1/
English
6
6
39
5.9K
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
Data sharing for publication: We need a better solution than dbGAP and EGA. They are over-burdened, but waiting 3 months to get an accession number and even longer for data to be released is a curse to research progress. There must be another way.
English
1
1
11
867
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
Save-the-date: AACR/ICML Advances In Malignant Lymphoma, June 24-27, 2026, Philadelphia. Featuring interactive sessions focused on the cutting edge of basic and translational research in Lymphoma. @AACR @icmlugano #lmsm
English
0
3
27
1.4K
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
Thrilled to see @dgermain21 present our work as a plenary at #18ICML, with excellent discussion from Steve Ansell. The paper will be online tonight, with a summary to follow.
Michael Green, PhD tweet media
English
7
5
49
3.1K
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
For those of you who have had a hard time with papers, this was a doozie. Several editorial desk rejections, all for different reasons, and then an extensive 41-page rebuttal required for revision at Blood. All told, ~2 years from first submission to acceptance. Just keep at it!!
Michael Green, PhD@GreenLymphoLab

Now online, a monster effort from Haopeng Yang & Wenchao Zhang in collaboration with Fernando Rodrigues-Lima @univ_paris_cite: Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement. #lmsm ashpublications.org/blood/article/…

English
0
0
14
973
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
Why is it that journals do not have the same data sharing standards for pharma as they do for academia? There is always a vague statement that you can email the company to request the data. But, after you've told the company all your ideas, the answer is invariably no.
English
0
0
7
1.8K

ค้นพบ

@NatureGenet @IamLinghua @biorxiv @ESHaematology @DelgoffeLab @MDAndersonNews @AACR @icmlugano